|
Index of reports
> Cases with Pain (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Scopolamine where reactions include pain. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Scopolamine side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-25
Patient: 28 year old female, weighing 95.0 kg (209.0 pounds)
Reactions: Pain, Liver Function Test Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Atracurium Besylate
Indication: General Anaesthesia
Suprane
Indication: Choledocholithotomy
Cyclizine
Indication: General Anaesthesia
Remifentanil
Indication: General Anaesthesia
Suprane
Dosage: unk
Indication: General Anaesthesia
Start date: 2011-10-11
Fentanyl Citrate
Indication: General Anaesthesia
Dexamethasone Sodium Phosphate
Indication: General Anaesthesia
Scopolamine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-10
End date: 2011-10-10
Ondansetron HCL
Indication: General Anaesthesia
Meperidine HCL
Dosage: unk
Indication: General Anaesthesia
Start date: 2011-10-10
End date: 2011-10-10
Possible Scopolamine side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-28
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: Weight Decreased, Drug Ineffective, Pain, Mental Status Changes, Constipation, Gastric Ulcer, Hypokalaemia, Malignant Pleural Effusion, Oedema Peripheral, Depression, Acute Respiratory Failure, Gastrooesophageal Reflux Disease, Anaemia Postoperative, Cough, Vomiting, Dyspnoea, Nausea, Anaemia, Catatonia, Anxiety, Acute Sinusitis, Diarrhoea, Neoplasm Malignant, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Scopolamine
Indication: Vomiting
Marinol
Indication: Vomiting
Dasatinib
Dosage: 20 mg, uid/qd
Administration route: Oral
Start date: 2011-12-02
End date: 2012-03-04
Dasatinib
Dosage: 50 mg, uid/qd
Administration route: Oral
Reglan
Dosage: 5 mg, bid
Administration route: Oral
Indication: Nausea
Phenergan HCL
Indication: Vomiting
Klonopin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Dasatinib
Dosage: 20 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2011-12-02
End date: 2012-01-06
Dasatinib
Dosage: 50 mg, uid/qd
Administration route: Oral
Start date: 2011-12-02
End date: 2012-01-06
Marinol
Dosage: 2.5 mg, bid
Administration route: Oral
Indication: Nausea
Scopolamine
Dosage: 1 df, q72hrs
Administration route: Topical
Indication: Nausea
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Start date: 2012-01-20
End date: 2012-03-04
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2011-12-02
End date: 2012-01-06
Dasatinib
Dosage: 50 mg, uid/qd
Administration route: Oral
Start date: 2012-01-20
End date: 2012-03-04
Reglan
Indication: Vomiting
Phenergan HCL
Dosage: 75 mg, q8 hours prn
Indication: Nausea
Other drugs received by patient: Lomotil; Calcium Carbonate; Zofran; Colestipol Hydrochloride; Hydrochlorothiazide; Fish OIL; Tylenol; Metoprolol Succinate; Lomotil; Effexor XR; Diovan; Ondansetron HCL; Tylenol; Toprol-XL; Timolol Maleate; Simvastatin; Evista; Norvasc; Clonazepam; Calcium +D; Zetia; Xalatan; Prevacid; Aspirin; Ondansetron HCL; Dronabinol
Possible Scopolamine side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-03-21
Patient: female
Reactions: Pain, Thermal Burn, Crying
Drug(s) suspected as cause:
Scopolamine
Dosage: unk, unk
Start date: 2011-11-01
End date: 2011-11-01
Scopolamine
Dosage: unk, unk
Start date: 2012-01-01
End date: 2012-01-01
Possible Scopolamine side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-29
Patient: 28 year old female, weighing 95.0 kg (209.0 pounds)
Reactions: Liver Function Test Abnormal, Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fentanyl Citrate
Indication: General Anaesthesia
Cyclizine
Indication: General Anaesthesia
Suprane
Dosage: unk
Indication: General Anaesthesia
Start date: 2011-10-11
Remifentanil
Indication: General Anaesthesia
Atracurium Besylate
Indication: General Anaesthesia
Ondansetron HCL
Indication: General Anaesthesia
Dexamethasone Sodium Phosphate
Indication: General Anaesthesia
Scopolamine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-10
End date: 2011-10-10
Meperidine HCL
Dosage: unk
Indication: General Anaesthesia
Start date: 2011-10-10
End date: 2011-10-10
Suprane
Indication: Choledocholithotomy
Possible Scopolamine side effects in 28 year old female
Reported by a physician from United States on 2012-02-22
Patient: 28 year old female, weighing 90.0 kg (198.0 pounds)
Reactions: Mydriasis, Hypercapnia, Tachycardia, Pain, Unresponsive To Stimuli, Hypoxia, Drug Interaction, Anticholinergic Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Scopolamine
Dosage: 1.5 mg (1.5 mg), transdermal
Indication: Prophylaxis of Nausea and Vomiting
Citalopram Hydrobromide
Indication: Depression
Other drugs received by patient: Fentanyl; Ondansetron; Propofol; Midazolam HCL; Dexamethasone
Possible Scopolamine side effects in 28 year old female
Reported by a physician from United Kingdom on 2012-02-21
Patient: 28 year old female, weighing 95.0 kg (209.0 pounds)
Reactions: Liver Function Test Abnormal, Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Meperidine HCL
Dosage: unk
Indication: General Anaesthesia
Start date: 2011-10-10
End date: 2011-10-10
Dexamethasone
Indication: General Anaesthesia
Suprane
Dosage: 1 df, single
Indication: General Anaesthesia
Start date: 2011-10-10
Scopolamine
Dosage: unk
Start date: 2011-10-10
End date: 2011-10-10
Suprane
Indication: Choledocholithotomy
Ondansetron
Indication: General Anaesthesia
Cyclizine
Indication: General Anaesthesia
Fentanyl
Indication: General Anaesthesia
Remifentanil
Indication: General Anaesthesia
Atracurium
Indication: General Anaesthesia
Possible Scopolamine side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-16
Patient: 28 year old female, weighing 90.0 kg (198.0 pounds)
Reactions: Mydriasis, Post Procedural Complication, Pain, Unresponsive To Stimuli, Arthroscopy, Drug Interaction, Anticholinergic Syndrome, Gaze Palsy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 8 mg;iv
Indication: Prophylaxis of Nausea and Vomiting
Fentanyl
Dosage: 100 ug;iv
Indication: Pain
Scopolamine
Dosage: 1.5 mg;tder
Indication: Prophylaxis of Nausea and Vomiting
Citalopram Hydrobromide
Indication: Obsessive-Compulsive Disorder
Propofol
Dosage: iv
Indication: General Anaesthesia
Ondansetron
Dosage: 4 mg;iv
Indication: Prophylaxis of Nausea and Vomiting
Possible Scopolamine side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-03
Patient: 28 year old female, weighing 95.0 kg (209.0 pounds)
Reactions: Pain, Liver Function Test Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Remifentanyl
Indication: General Anaesthesia
Atracurium
Indication: General Anaesthesia
Suprane
Indication: General Anaesthesia
Start date: 2011-10-11
Fentanyl Citrate
Indication: General Anaesthesia
Ondansetron
Indication: General Anaesthesia
Meperidine HCL
Indication: General Anaesthesia
Start date: 2011-10-10
End date: 2011-10-10
Scopolamine
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-10
End date: 2011-10-10
Cyclizine
Indication: General Anaesthesia
Suprane
Indication: Choledocholithotomy
Start date: 2011-10-11
Dexamethasone
Indication: General Anaesthesia
Possible Scopolamine side effects in female
Reported by a physician from United States on 2012-01-29
Patient: female, weighing 57.2 kg (125.8 pounds)
Reactions: Aphagia, Weight Decreased, Vomiting, Drug Ineffective, Drug Hypersensitivity, Crohn's Disease, Abasia, Pain, Application Site Pain, Local Swelling, Eczema, Anxiety, Neuropathy Peripheral, Laboratory Test Abnormal, Fibromyalgia, Sepsis, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Humira
Indication: Crohn's Disease
Scopolamine
Indication: Vomiting
Start date: 2011-01-01
End date: 2011-01-01
Pain Medication
Indication: Pain
Humira
Start date: 2011-05-01
End date: 2011-06-01
Other drugs received by patient: Fentanyl; Lyrica; Cimzia; Ondansetron HCL; Klonopin; Tramadol HCL; Oxycodone HCL; Phenergan; Cymbalta
Possible Scopolamine side effects in 13 year old male
Reported by a physician from United States on 2011-10-10
Patient: 13 year old male, weighing 39.6 kg (87.1 pounds)
Reactions: Anxiety, Confusional State, Akathisia, Pruritus, Pain, Chills, Anger, Memory Impairment, Paraesthesia
Drug(s) suspected as cause:
Methotrexate
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Pegaspargase
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Zofran
Indication: Product Used FOR Unknown Indication
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Bactrim
Indication: Product Used FOR Unknown Indication
Ranitidine
Indication: Product Used FOR Unknown Indication
Prednisone
Dosage: 20mgm2 cyclic
Administration route: Oral
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Benadryl
Indication: Product Used FOR Unknown Indication
Cytarabine
Indication: Precursor B-Lymphoblastic Lymphoma
Hydrocortisone
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Ativan
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3mgm2 cyclic
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Doxorubicin HCL
Dosage: 60mgm2 cyclic
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Scopolamine
Indication: Product Used FOR Unknown Indication
|
